Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Vitamin D Deficiency 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Thyroid Neoplasms 2 Lymphoma 2 Leukemia 2 Colonic Neoplasms 2 Adenomatous Polyps 2 Adenoma 2 Thyroiditis 1 Prostatic Neoplasms 1 Polyps 1 Polycystic Ovary Syndrome 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Obesity 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Hypocalcemia 1 Hyperthyroidism 1 Goiter 1 Colonic Polyps 1 Bone Diseases, Metabolic 1 Arthralgia 1 Aflatoxin Poisoning 1

Interventions

sodium calcium aluminosilicate, hydrated 1 Calcium Carbonate 1 ACCS100 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aflatoxin Poisoning × Calcium Carbonate × Clear all

NCT01677195 2016-04-19

RDMEACCS100

Texas Enterosorbents Incorporated

Phase 2 Completed

234 enrolled 7 charts

Aflatoxin Poisoning, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡